Wire · opportunities
AstraZeneca partners with Oracle for AI-driven clinical trials
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 October 2026 · Fusion42 review
AstraZeneca has partnered with Oracle to use AI and real-world data to improve patient recruitment and safety monitoring in clinical trials, initially focusing on diseases like cancer, cardiovascular, respiratory, immunology, and rare diseases. The collaboration aims to address key challenges in clinical research and enhance AstraZeneca's drug development capabilities.
This Wire brief sits within Fusion42's coverage of Biotech, and 5 sources have reported it.
◆ ◆ The Wire takeaway
You face a new way to cut clinical trial delays by using AI to match patients and monitor safety in real-world settings. Start exploring partnerships with AI platforms in clinical research to speed up drug development and reduce costs.
◆ Coverage
5 sources · 20 Oct 2026
◆ Related on Wire
◆ Topics